3-deazaadenosine	O
,	O
a	O
S-adenosylhomocysteine	B-protein
hydrolase	I-protein
inhibitor	O
,	O
has	O
dual	O
effects	O
on	O
NF-kappaB	B-protein
regulation	O
.	O

Inhibition	O
of	O
NF-kappaB	B-protein
transcriptional	O
activity	O
and	O
promotion	O
of	O
IkappaBalpha	B-protein
degradation	O
.	O

Previously	O
we	O
reported	O
that	O
3-deazaadenosine	O
(	O
DZA	O
)	O
,	O
a	O
potent	O
inhibitor	O
and	O
substrate	O
for	O
S-adenosylhomocysteine	B-protein
hydrolase	I-protein
inhibits	O
bacterial	O
lipopolysaccharide-induced	O
transcription	O
of	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
and	O
interleukin-1beta	B-protein
in	O
mouse	B-cell_line
macrophage	I-cell_line
RAW	I-cell_line
264.7	I-cell_line
cells	I-cell_line
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
the	O
effects	O
of	O
DZA	O
on	O
nuclear	B-protein
factor-kappaB	I-protein
(	O
NF-kappaB	B-protein
)	O
regulation	O
.	O

DZA	O
inhibits	O
the	O
transcriptional	O
activity	O
of	O
NF-kappaB	B-protein
through	O
the	O
hindrance	O
of	O
p65	B-protein
(	O
Rel-A	B-protein
)	O
phosphorylation	O
without	O
reduction	O
of	O
its	O
nuclear	O
translocation	O
and	O
DNA	O
binding	O
activity	O
.	O

The	O
inhibitory	O
effect	O
of	O
DZA	O
on	O
NF-kappaB	B-protein
transcriptional	O
activity	O
is	O
potentiated	O
by	O
the	O
addition	O
of	O
homocysteine	O
.	O

Taken	O
together	O
,	O
DZA	O
promotes	O
the	O
proteolytic	O
degradation	O
of	O
IkappaBalpha	B-protein
,	O
but	O
not	O
IkappaBbeta	B-protein
,	O
resulting	O
in	O
an	O
increase	O
of	O
DNA	O
binding	O
activity	O
of	O
NF-kappaB	B-protein
in	O
the	O
nucleus	O
in	O
the	O
absence	O
of	O
its	O
transcriptional	O
activity	O
in	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
.	O

The	O
reduction	O
of	O
IkappaBalpha	B-protein
by	O
DZA	O
is	O
neither	O
involved	O
in	O
IkappaB	B-protein
kinase	I-protein
complex	I-protein
activation	O
nor	O
modulated	O
by	O
the	O
addition	O
of	O
homocysteine	O
.	O

This	O
study	O
strongly	O
suggests	O
that	O
DZA	O
may	O
be	O
a	O
potent	O
drug	O
for	O
the	O
treatment	O
of	O
diseases	O
in	O
which	O
NF-kappaB	B-protein
plays	O
a	O
central	O
pathogenic	O
role	O
,	O
as	O
well	O
as	O
a	O
useful	O
tool	O
for	O
studying	O
the	O
regulation	O
and	O
physiological	O
functions	O
of	O
NF-kappaB	B-protein
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

27	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
2	NULL
,	NULL
pp	NULL
.	NULL

18981-18988	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
3-Deazaadenosine	NULL
,	NULL
a	NULL
S-Adenosylhomocysteine	NULL
Hydrolase	NULL
Inhibitor	NULL
,	NULL
Has	NULL
Dual	NULL
Effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
Regulation	NULL
INHIBITION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
AND	NULL
PROMOTION	NULL
OF	NULL
I	NULL
«	NULL
xBa	NULL
DEGRADATION*®	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
November	NULL
19	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
22	NULL
,	NULL
1999	NULL
)	NULL
Seong-Yun	NULL
Jeong+	NULL
#	NULL
,	NULL
Sang-Gun	NULL
Ahnt	NULL
,	NULL
Jeong-Hwa	NULL
Leet	NULL
,	NULL
Ho-Shik	NULL
Kim	NULL
?	NULL

#	NULL
,	NULL
Jin-Woo	NULL
Kim	NULL
{	NULL
,	NULL
Hyangshuk	NULL
Rhim§	NULL
,	NULL
Seong-Whan	NULL
Jeongt	NULL
#	NULL
,	NULL
and	NULL
In-Kyung	NULL
Kim	NULL
#	NULL
§1	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
§Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
The	NULL
Catholic	NULL
University	NULL
of	NULL
Korea	NULL
,	NULL
Seoul	NULL
137-701	NULL
,	NULL
Korea	NULL
Previously	NULL
we	NULL
reported	NULL
that	NULL
3-deazaadenosine	NULL
(	NULL
DZA	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
and	NULL
substrate	NULL
for	NULL
S-adenosylhomocysteine	NULL
hydrolase	NULL
inhibits	NULL
bacterial	NULL
lipopolysaccharide-induced	NULL
transcription	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
and	NULL
interleukin-1	NULL
in	NULL
mouse	NULL
macrophage	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
the	NULL
effects	NULL
of	NULL
DZA	NULL
on	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
regulation	NULL
.	NULL

DZA	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
the	NULL
hindrance	NULL
of	NULL
p65	NULL
(	NULL
Rel-A	NULL
)	NULL
phosphorylation	NULL
without	NULL
reduction	NULL
of	NULL
its	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
transcriptional	NULL
activity	NULL
is	NULL
potentiated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
homocysteine	NULL
.	NULL

Taken	NULL
to-gether	NULL
,	NULL
DZA	NULL
promotes	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
but	NULL
not	NULL
IBB	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-B	NULL
in	NULL
the	NULL
nucleus	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
its	NULL
transcriptional	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
reduction	NULL
of	NULL
IxBa	NULL
by	NULL
DZA	NULL
is	NULL
neither	NULL
involved	NULL
in	NULL
IB	NULL
kinase	NULL
complex	NULL
activation	NULL
nor	NULL
modulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
homocysteine	NULL
.	NULL

This	NULL
study	NULL
strongly	NULL
suggests	NULL
that	NULL
DZA	NULL
may	NULL
be	NULL
a	NULL
potent	NULL
drug	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
diseases	NULL
in	NULL
which	NULL
NF-xB	NULL
plays	NULL
a	NULL
central	NULL
pathogenic	NULL
role	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
useful	NULL
tool	NULL
for	NULL
studying	NULL
the	NULL
regulation	NULL
and	NULL
physiological	NULL
functions	NULL
of	NULL
NF-KB	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
``	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
fac-tor	NULL
,	NULL
is	NULL
a	NULL
pivotal	NULL
regulator	NULL
of	NULL
immune	NULL
responses	NULL
,	NULL
inflammation	NULL
,	NULL
cell	NULL
proliferation	NULL
,	NULL
oncogenesis	NULL
,	NULL
and	NULL
apoptosis	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

A	NULL
prototype	NULL
member	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
,	NULL
hetero-	NULL
or	NULL
homodimeric	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
is	NULL
made	NULL
from	NULL
monomers	NULL
that	NULL
have	NULL
a	NULL
highly	NULL
conserved	NULL
approximately	NULL
300-amino	NULL
acid	NULL
amino-terminal	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
called	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
functions	NULL
in	NULL
DNA	NULL
binding	NULL
,	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
funding	NULL
from	NULL
the	NULL
1995	NULL
and	NULL
1997	NULL
Basic	NULL
Research	NULL
Promotion	NULL
Fund	NULL
of	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Korea	NULL
,	NULL
and	NULL
the	NULL
Korea	NULL
Science	NULL
and	NULL
Engineering	NULL
Foundation	NULL
(	NULL
KOSEF	NULL
)	NULL
,	NULL
Cancer	NULL
Research	NULL
Center	NULL
at	NULL
Seoul	NULL
National	NULL
University	NULL
,	NULL
Grant	NULL
97K4-0401-00-01-3	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

«	NULL
]	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Biochemistry	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
The	NULL
Catholic	NULL
University	NULL
of	NULL
Korea	NULL
,	NULL
Seoul	NULL
1837-701	NULL
,	NULL
Korea	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
82-2-590-1175	NULL
;	NULL
Fax	NULL
:	NULL
82-2-596-4485	NULL
;	NULL
E-mail	NULL
:	NULL
ikkim	NULL
@	NULL
eme.culk.ac.kr	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
;	NULL
DZA	NULL
,	NULL
8-dea-zaadenosine	NULL
;	NULL
Hey	NULL
,	NULL
homocysteine	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
IKK	NULL
,	NULL
IxB	NULL
kinase	NULL
;	NULL
PBMC	NULL
,	NULL
human	NULL
peripheral	NULL
blood	NULL
mono-cytes	NULL
;	NULL
DZA-Hey	NULL
,	NULL
S3-deazaadenosylhomocysteine	NULL
;	NULL
IL-1	NULL
,	NULL
interleukin-1	NULL
;	NULL
DZAri	NULL
,	NULL
8-deaza-	NULL
(	NULL
+*	NULL
)	NULL
-aristeromycin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
PKAc	NULL
,	NULL
catalytic	NULL
subunit	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
DTT	NULL
,	NULL
dithio-threitol	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
nuclear	NULL
translocation	NULL
,	NULL
formation	NULL
of	NULL
dimers	NULL
,	NULL
and	NULL
I	NULL
«	NULL
B	NULL
binding	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
dimeric	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
are	NULL
stored	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
unstimulated	NULL
cells	NULL
as	NULL
inactive	NULL
complexes	NULL
through	NULL
interactions	NULL
with	NULL
a	NULL
group	NULL
of	NULL
inhibitory	NULL
proteins	NULL
called	NULL
IB	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
vertebrate	NULL
I	NULL
«	NULL
B	NULL
family	NULL
such	NULL
as	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
Bel-3	NULL
,	NULL
precursor	NULL
proteins	NULL
p105	NULL
and	NULL
p100	NULL
,	NULL
and	NULL
IxBe	NULL
were	NULL
reported	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Inactive	NULL
cytoplasmic	NULL
NF-kB	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
NF-	NULL
«	NULL
B-inducing	NULL
agents	NULL
including	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
.	NULL

Despite	NULL
differences	NULL
among	NULL
these	NULL
stimuli	NULL
,	NULL
one	NULL
of	NULL
their	NULL
common	NULL
targets	NULL
is	NULL
the	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B-IxB	NULL
complexes	NULL
.	NULL

These	NULL
signals	NULL
known	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
result	NULL
in	NULL
phosphoryla-tion	NULL
,	NULL
subsequent	NULL
ubiquitination	NULL
,	NULL
and	NULL
proteasome-mediated	NULL
degradation	NULL
of	NULL
the	NULL
IxB	NULL
proteins	NULL
,	NULL
allowing	NULL
NF-B	NULL
to	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
bind	NULL
to	NULL
specific	NULL
kB	NULL
sites	NULL
and	NULL
thereby	NULL
activate	NULL
target	NULL
genes	NULL
such	NULL
as	NULL
various	NULL
cytokines	NULL
,	NULL
cell	NULL
adhesion	NULL
molecules	NULL
,	NULL
acute-phase	NULL
proteins	NULL
,	NULL
and	NULL
immunoreceptors	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Researchers	NULL
have	NULL
long	NULL
searched	NULL
to	NULL
identify	NULL
IxB	NULL
kinase	NULL
which	NULL
phosphoryl-ates	NULL
the	NULL
IxB	NULL
proteins	NULL
to	NULL
initiate	NULL
the	NULL
activation	NULL
cascade	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Recently	NULL
,	NULL
IxB	NULL
kinase	NULL
«	NULL
(	NULL
IKKa	NULL
)	NULL
and	NULL
IB	NULL
kinase	NULL
B	NULL
(	NULL
IKKB	NULL
)	NULL
were	NULL
reported	NULL
as	NULL
essential	NULL
kinases	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
downstream	NULL
of	NULL
TNF-a	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
receptors	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
be	NULL
inhibited	NULL
through	NULL
diverse	NULL
mechanisms	NULL
by	NULL
manifold	NULL
compounds	NULL
at	NULL
distinct	NULL
positions	NULL
in	NULL
the	NULL
activation	NULL
cascade	NULL
.	NULL

One	NULL
group	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
which	NULL
share	NULL
the	NULL
property	NULL
of	NULL
being	NULL
anti-oxidative	NULL
,	NULL
includes	NULL
N-acetyl-L-cys-teine	NULL
(	NULL
10	NULL
)	NULL
,	NULL
acetylsalicylic	NULL
acid	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
pyrrolidine	NULL
dithiocar-bamate	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Some	NULL
inhibitors	NULL
interrupt	NULL
the	NULL
induced	NULL
degradation	NULL
of	NULL
IB	NULL
proteins	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
26	NULL
S	NULL
protease	NULL
(	NULL
13	NULL
)	NULL
,	NULL
or	NULL
by	NULL
increase	NULL
of	NULL
IxBa	NULL
synthesis	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Another	NULL
group	NULL
of	NULL
inhibitors	NULL
hinders	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
already	NULL
bound	NULL
to	NULL
DNA	NULL
.	NULL

This	NULL
group	NULL
includes	NULL
SB203580	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
elevated	NULL
intracellular	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

3-Deazaadenosine	NULL
(	NULL
DZA	NULL
)	NULL
was	NULL
developed	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
most	NULL
potent	NULL
inhibitors	NULL
of	NULL
S-adenosylhomocysteine	NULL
hydrolase	NULL
(	NULL
EC	NULL
3.8.1.1	NULL
)	NULL
(	NULL
18	NULL
)	NULL
.	NULL

This	NULL
agent	NULL
binds	NULL
to	NULL
S-adenosylhomocysteine	NULL
hydrolase	NULL
resulting	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
S-adenosylhomocysteine	NULL
and	NULL
S-adenosylmethionine	NULL
,	NULL
and	NULL
serves	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
the	NULL
enzyme	NULL
resulting	NULL
in	NULL
the	NULL
huge	NULL
accumulation	NULL
of	NULL
3-deazaade-nosylhomocysteine	NULL
(	NULL
DZA-Hcy	NULL
)	NULL
in	NULL
cultured	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
especially	NULL
in	NULL
liver	NULL
tissue	NULL
(	NULL
20	NULL
)	NULL
.	NULL

DZA	NULL
exerts	NULL
a	NULL
number	NULL
of	NULL
interesting	NULL
biological	NULL
properties	NULL
,	NULL
such	NULL
as	NULL
anti-human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
activity	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
effects	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
lymphocyte-medi-ated	NULL
cytolysis	NULL
(	NULL
25	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
cytokine	NULL
expression	NULL
including	NULL
TNF-	NULL
«	NULL
and	NULL
IL-18B	NULL
(	NULL
26	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
cell	NULL
adhesion	NULL
molecule	NULL
expression	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
leukemia	NULL
cells	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
wide	NULL
variety	NULL
of	NULL
biological	NULL
properties	NULL
underscores	NULL
that	NULL
DZA	NULL
is	NULL
to	NULL
be	NULL
an	NULL
effective	NULL
18981	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
18982	NULL
drug	NULL
for	NULL
treatment	NULL
of	NULL
many	NULL
human	NULL
diseases	NULL
,	NULL
the	NULL
action	NULL
mechanism	NULL
of	NULL
DZA	NULL
is	NULL
not	NULL
yet	NULL
fully	NULL
understood	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
DZA	NULL
inhibits	NULL
LPS-induced	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1B	NULL
transcription	NULL
in	NULL
mouse	NULL
macrophage	NULL
RAW264.7	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
elementary	NULL
experiments	NULL
confirming	NULL
DZA	NULL
inhibition	NULL
of	NULL
TNF-	NULL
«	NULL
transcription	NULL
in	NULL
human	NULL
monocytic	NULL
macrophage	NULL
THP-1	NULL
cells	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
PBMC	NULL
)	NULL
encouraged	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
NF-KB	NULL
activation	NULL
with	NULL
the	NULL
intention	NULL
of	NULL
understanding	NULL
the	NULL
cellular	NULL
mechanism	NULL
of	NULL
DZA	NULL
.	NULL

DZA	NULL
potently	NULL
inhibited	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
the	NULL
hindrance	NULL
of	NULL
p65	NULL
phosphorylation	NULL
without	NULL
reduction	NULL
of	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
DZA	NULL
promoted	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
DZA	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
potent	NULL
drug	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
diseases	NULL
in	NULL
which	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
an	NULL
important	NULL
pathogenic	NULL
role	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
useful	NULL
tool	NULL
for	NULL
studying	NULL
the	NULL
regulation	NULL
and	NULL
physiological	NULL
functions	NULL
of	NULL
NF-kB	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Chemicals-DZA	NULL
,	NULL
3-deaza-	NULL
(	NULL
*	NULL
)	NULL
-aristeromycin	NULL
(	NULL
DZAri	NULL
)	NULL
,	NULL
and	NULL
DZA-Hey	NULL
were	NULL
donated	NULL
by	NULL
Dr.	NULL
Chiang	NULL
of	NULL
the	NULL
Walter	NULL
Reed	NULL
Army	NULL
Institute	NULL
of	NULL
Research	NULL
,	NULL
Washington	NULL
,	NULL
D.C.	NULL
Hcy-thiolactone	NULL
and	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
,	NULL
No	NULL
.	NULL

0127	NULL
B-8	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Recombinant	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
protein	NULL
of	NULL
human	NULL
TNF-	NULL
«	NULL
and	NULL
GST	NULL
human	NULL
I	NULL
«	NULL
Ba	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Dae-Myung	NULL
Jue	NULL
in	NULL
our	NULL
de-partment	NULL
.	NULL

Unless	NULL
specified	NULL
otherwise	NULL
,	NULL
all	NULL
reagents	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Cell	NULL
Culture-Mouse	NULL
macrophage	NULL
RAW	NULL
264.7	NULL
,	NULL
human	NULL
monocytic	NULL
THP-1	NULL
,	NULL
and	NULL
SV40-transformed	NULL
African	NULL
green	NULL
monkey	NULL
kidney	NULL
COS-7	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

PBMC	NULL
were	NULL
isolated	NULL
from	NULL
defibrinated	NULL
blood	NULL
using	NULL
Ficoll-Hypaque	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
by	NULL
density-gradient	NULL
separation	NULL
,	NULL
followed	NULL
by	NULL
adherence	NULL
to	NULL
tissue	NULL
culture	NULL
dish	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
the	NULL
monolayer	NULL
four	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
25	NULL
mM	NULL
sodium	NULL
bicarbonate	NULL
,	NULL
50	NULL
ug/ml	NULL
gentamicin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
heat-inacti-vated	NULL
(	NULL
56	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
,	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
at	NULL
2	NULL
h	NULL
after	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
stimulation	NULL
according	NULL
to	NULL
a	NULL
previously	NULL
described	NULL
method	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Five	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
2.2	NULL
M	NULL
formaldehyde	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
digoxigenin	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
-labeled	NULL
probes	NULL
were	NULL
prepared	NULL
from	NULL
each	NULL
specific	NULL
primer	NULL
and	NULL
cDNA	NULL
fragments	NULL
of	NULL
amplimer	NULL
sets	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Preparation	NULL
of	NULL
Cytoplasmic	NULL
Fraction	NULL
and	NULL
Nuclear	NULL
Extract-After	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
mg/m	NULL
!	NULL
)	NULL

for	NULL
1	NULL
h	NULL
and	NULL
COS-7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
recombinant	NULL
GST-human	NULL
TNF-a	NULL
protein	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Cytosolic	NULL
fraction	NULL
and	NULL
nuclear	NULL
extract	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
82	NULL
)	NULL
.	NULL

Concentration	NULL
of	NULL
protein	NULL
was	NULL
determined	NULL
using	NULL
Coomassie	NULL
Plus	NULL
Protein	NULL
Assay	NULL
Reagent	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

EMSA-Five	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
per	NULL
reaction	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
NF-kB	NULL
consensus	NULL
sequence	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnol-ogy	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
which	NULL
was	NULL
3'-end	NULL
labeled	NULL
with	NULL
``	NULL
°P	NULL
,	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
my	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
,80	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.2	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Tween	NULL
20	NULL
,	NULL
30	NULL
mM	NULL
KCl	NULL
)	NULL
.	NULL

After	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
that	NULL
was	NULL
run	NULL
in	NULL
0.5	NULL
%	NULL
Tris	NULL
borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
buffer	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
and	NULL
then	NULL
the	NULL
dried	NULL
gel	NULL
was	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

For	NULL
competi-tion	NULL
,	NULL
50-fold	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis-Ten	NULL
ug	NULL
of	NULL
proteins	NULL
were	NULL
subjected	NULL
to	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
or	NULL
12.5	NULL
%	NULL
SDS-PAGE	NULL
for	NULL
IxB	NULL
proteins	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitro-cellulose	NULL
membrane	NULL
in	NULL
transfer	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
198	NULL
mM	NULL
gly-cine	NULL
,	NULL
20	NULL
%	NULL
methanol	NULL
)	NULL
at	NULL
500	NULL
mA	NULL
for	NULL
4	NULL
h.	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

All	NULL
primary	NULL
antibodies	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
anti-p65	NULL
(	NULL
C-20	NULL
)	NULL
,	NULL
anti-p50	NULL
(	NULL
NLS	NULL
)	NULL
,	NULL
anti-c-Rel	NULL
(	NULL
N	NULL
)	NULL
,	NULL
anti-IkB	NULL
@	NULL
/MAD-8	NULL
(	NULL
C-21	NULL
)	NULL
,	NULL
and	NULL
anti-IxBB	NULL
(	NULL
C-20	NULL
)	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Plasmids	NULL
and	NULL
Transient	NULL
Transfection	NULL
Analysis-Plasmid	NULL
J16	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
,	NULL
and	NULL
J82	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
mutant	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
,	NULL
upstream	NULL
of	NULL
a	NULL
truncated	NULL
c-fos	NULL
promoter	NULL
which	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
(	NULL
838	NULL
)	NULL
,	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
David	NULL
Baltimore	NULL
of	NULL
California	NULL
Institute	NULL
of	NULL
Technology	NULL
,	NULL
Pasadena	NULL
,	NULL
CA	NULL
.	NULL

pSVL65	NULL
expressing	NULL
p65	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
a	NULL
SV40	NULL
promoter	NULL
was	NULL
kindly	NULL
donated	NULL
by	NULL
Dr.	NULL
Mahnhoon	NULL
Park	NULL
of	NULL
Mogam	NULL
Biotechnology	NULL
Research	NULL
Institute	NULL
,	NULL
Yon-gin	NULL
,	NULL
Kyunggi-do	NULL
,	NULL
Korea	NULL
.	NULL

pSVL	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
taking	NULL
the	NULL
place	NULL
of	NULL
pSVL65	NULL
.	NULL

To	NULL
assess	NULL
variations	NULL
in	NULL
transfection	NULL
efficiencies	NULL
,	NULL
a	NULL
control	NULL
plasmid	NULL
pCMVB	NULL
(	NULL
CLONTECH	NULL
)	NULL
which	NULL
expresses	NULL
the	NULL
LacZ	NULL
gene	NULL
was	NULL
used	NULL
.	NULL

Transfection	NULL
of	NULL
cells	NULL
was	NULL
performed	NULL
using	NULL
FuGENE	NULL
6	NULL
Transfection	NULL
Reagent	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
according	NULL
to	NULL
a	NULL
procedure	NULL
recommended	NULL
by	NULL
the	NULL
manufac-turer	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
either	NULL
J16	NULL
or	NULL
J82	NULL
were	NULL
cultured	NULL
for	NULL
18	NULL
h	NULL
,	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
LPS	NULL
or	NULL
TNF-a	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
DZA	NULL
alone	NULL
or	NULL
DZA	NULL
with	NULL
Hey	NULL
together	NULL
.	NULL

For	NULL
the	NULL
pSVL65	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
100	NULL
uM	NULL
DZA	NULL
at	NULL
6	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
further	NULL
incubated	NULL
for	NULL
18	NULL
h.	NULL
Induction	NULL
of	NULL
CAT	NULL
expression	NULL
was	NULL
determined	NULL
using	NULL
CAT	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
and	NULL
standardized	NULL
to	NULL
constitutive	NULL
levels	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

In	NULL
Vivo	NULL
Labeling	NULL
and	NULL
Immunoprecipitation-Confluent	NULL
monolayers	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
in	NULL
10-cm	NULL
tissue	NULL
culture	NULL
dishes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-free	NULL
Dulbecco	NULL
's	NULL
minimum	NULL
essential	NULL
medium	NULL
and	NULL
incubated	NULL
in	NULL
phosphate-free	NULL
Dulbecco	NULL
's	NULL
minimal	NULL
essential	NULL
medium	NULL
for	NULL
1	NULL
h.	NULL
Media	NULL
was	NULL
replaced	NULL
by	NULL
fresh	NULL
phosphate-free	NULL
Dulbecco	NULL
's	NULL
minimal	NULL
essential	NULL
medium	NULL
containing	NULL
100	NULL
mCi	NULL
of	NULL
°°P	NULL
;	NULL
per	NULL
ml	NULL
(	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h.	NULL
Cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
DZA	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
1	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
p65	NULL
was	NULL
recovered	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
anti-p65	NULL
(	NULL
C-20	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Bio-tech	NULL
)	NULL
.	NULL

The	NULL
immunopellets	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
gel	NULL
was	NULL
stained	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
R-250	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
equal	NULL
amount	NULL
of	NULL
protein	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
wall	NULL
.	NULL

Dried	NULL
gel	NULL
was	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

IKK	NULL
Assay-RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
DZA	NULL
for	NULL
various	NULL
time	NULL
intervals	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
IKK	NULL
assay	NULL
.	NULL

IKK	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
84	NULL
)	NULL
,	NULL
using	NULL
recombinant	NULL
protein	NULL
of	NULL
GST-human	NULL
IkBa	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

A	NULL
polyclonal	NULL
antibody	NULL
to	NULL
IKKa	NULL
(	NULL
M-280	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

RESULTS	NULL
LPS-induced	NULL
Expression	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
Is	NULL
Inhibited	NULL
by	NULL
DZA-Transcription	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
was	NULL
inhibited	NULL
by	NULL
DZA	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
by	NULL
LPS	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
DZA	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
TNF-a	NULL
in	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
THP-1	NULL
cells	NULL
and	NULL
PBMC	NULL
were	NULL
pretreated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
LPS	NULL
stimulation	NULL
increased	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
as	NULL
early	NULL
as	NULL
2	NULL
h.	NULL
Treatment	NULL
of	NULL
DZA	NULL
inhibited	NULL
the	NULL
LPS-induced	NULL
expression	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
dose	NULL
dependently	NULL
in	NULL
both	NULL
THP-1	NULL
cells	NULL
and	NULL
PBMC	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
B-actin	NULL
mRNA	NULL
as	NULL
a	NULL
control	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
DZA	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
DZA	NULL
efficiently	NULL
inhibits	NULL
the	NULL
LPS-induced	NULL
expression	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
and	NULL
this	NULL
potency	NULL
is	NULL
not	NULL
only	NULL
restricted	NULL
to	NULL
murine	NULL
macrophage	NULL
cells	NULL
.	NULL

DNA	NULL
Binding	NULL
Activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Is	NULL
Increased	NULL
by	NULL
DZA-Since	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
indispensable	NULL
for	NULL
TNF-a	NULL
expression	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
85	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
by	NULL
EMSA	NULL
,	NULL
using	NULL
°°P-labeled	NULL
NF-kB	NULL
specific	NULL
oligonucleotides	NULL
.	NULL

An	NULL
inducible	NULL
protein-DNA	NULL
complex	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS-stimulated	NULL
RAW	NULL
264.7	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
cells	NULL
pretreated	NULL
with	NULL
DZA	NULL
revealed	NULL
no	NULL
significant	NULL
decrease	NULL
of	NULL
the	NULL
LPS-induced	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
DZA	NULL
-	NULL
-	NULL
1	NULL
10	NULL
10	NULL
1	NULL
1	NULL
10	NULL
LPS	NULL
-	NULL
t	NULL
to	NULL
t	NULL
to	NULL
-	NULL
o+	NULL
+	NULL
+o	NULL
+	NULL
RAW	NULL
264.7	NULL
(	NULL
v	NULL
e	NULL
o	NULL
o	NULL
#	NULL
THP-1	NULL
w	NULL
w	NULL
@	NULL
000	NULL
®	NULL
PBMC	NULL
we	NULL
+	NULL
...	NULL
``	NULL
TNF-	NULL
a	NULL
B	NULL
-actin	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

LPS-induced	NULL
expression	NULL
of	NULL
TNF-a	NULL
«	NULL
mRNA	NULL
is	NULL
inhibited	NULL
by	NULL
DZA	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
with	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
dosages	NULL
(	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
LPS	NULL
.	NULL

At	NULL
2	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/m1	NULL
)	NULL
,	NULL
total	NULL
RNAs	NULL
were	NULL
extracted	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Data	NULL
illustrated	NULL
are	NULL
from	NULL
a	NULL
single	NULL
experiment	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
total	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

A	NULL
DZA	NULL
_	NULL
-	NULL
-	NULL
1	NULL
#	NULL
10	NULL
1	NULL
9	NULL
10	NULL
LPS	NULL
-	NULL
+	NULL
k	NULL
40A	NULL
-	NULL
-o	NULL
B	NULL
x	NULL
B	NULL
willie	NULL
dili	NULL
=s	NULL
Sy	NULL
om	NULL
-	NULL
+	NULL
AP-1	NULL
0	NULL
-	NULL
-	NULL
400	NULL
-	NULL
bo	NULL
o-	NULL
-	NULL
+	NULL
eo	NULL
W	NULL
A	NULL
A	NULL
A	NULL
AoA	NULL
LPS	NULL
A	NULL
P	NULL
LPS+DZA	NULL
__	NULL
DZ	NULL
C	NULL
DIA	NULL
:	NULL
-==	NULL
#	NULL
%	NULL
CPS	NULL
:	NULL
=	NULL
%	NULL
#	NULL
>	NULL
NF-	NULL
«	NULL
6	NULL
>	NULL
>	NULL
p	NULL
)	NULL
(	NULL
iG	NULL
)	NULL
for	NULL
w/o	NULL
DTT	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

DNA	NULL
binding	NULL
activity	NULL
of	NULL
is	NULL
increased	NULL
by	NULL
DZA	NULL
.	NULL

A	NULL
,	NULL
dose-response	NULL
effect	NULL
of	NULL
DZA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
or	NULL
not	NULL
stimulated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
1	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
each	NULL
nuclear	NULL
protein	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
DNA	NULL
binding	NULL
reaction	NULL
with	NULL
``	NULL
°P-end-labeled	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
,	NULL
and	NULL
then	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

B	NULL
,	NULL
competition	NULL
experiments	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
using	NULL
50-fold	NULL
cold	NULL
NF-kB	NULL
binding	NULL
oligonucleotide	NULL
or	NULL
AP-1	NULL
.	NULL

C	NULL
,	NULL
removal	NULL
of	NULL
DTT	NULL
in	NULL
EMSA	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
DNA	NULL
binding	NULL
reactions	NULL
were	NULL
accomplished	NULL
without	NULL
DTT	NULL
.	NULL

Data	NULL
illustrated	NULL
are	NULL
from	NULL
a	NULL
single	NULL
experiment	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
total	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
even	NULL
though	NULL
expression	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
was	NULL
potently	NULL
inhibited	NULL
by	NULL
exposure	NULL
to	NULL
DZA	NULL
.	NULL

More-over	NULL
,	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
potentiated	NULL
in	NULL
nuclear	NULL
extracts	NULL
dose	NULL
dependently	NULL
by	NULL
DZA	NULL
,	NULL
irrespective	NULL
of	NULL
LPS	NULL
stimulation	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
a	NULL
50-fold	NULL
amount	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B-specific	NULL
oligonucleotide	NULL
absolutely	NULL
inhibited	NULL
typical	NULL
binding	NULL
activities	NULL
,	NULL
but	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
oligonucleotide	NULL
failed	NULL
to	NULL
inhibit	NULL
binding	NULL
activities	NULL
,	NULL
confirming	NULL
their	NULL
speci-ficities	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
by	NULL
DZA	NULL
occurred	NULL
without	NULL
down-regula-tion	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
that	NULL
DZA	NULL
increases	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
reducing	NULL
agent	NULL
such	NULL
as	NULL
DTT	NULL
in	NULL
preparation	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
and	NULL
the	NULL
execution	NULL
of	NULL
EMSA	NULL
could	NULL
mask	NULL
lost	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
,	NULL
we	NULL
repeated	NULL
the	NULL
EMSA	NULL
assay	NULL
18983	NULL
A	NULL
DZA	NULL
-	NULL
-	NULL
++	NULL
LPS	NULL
-	NULL
+	NULL
+	NULL
pes	NULL
(	NULL
wwe	NULL
ne	NULL
pN	NULL
-e	NULL
@	NULL
@	NULL
«	NULL
¢-Higl	NULL
mme	NULL
B	NULL
-	NULL
DZA	NULL
-	NULL
-	NULL
1	NULL
i010	NULL
1	NULL
10	NULL
100	NULL
LPS	NULL
tot	NULL
$	NULL
o	NULL
#	NULL
-	NULL
PGS	NULL
=	NULL
-	NULL
«	NULL
--	NULL
-	NULL
@	NULL
m	NULL
-	NULL
--	NULL
«	NULL
m	NULL
»	NULL
G	NULL
Min	NULL
0	NULL
5	NULL
10	NULL
15	NULL
x	NULL
3	NULL
60	NULL
120	NULL
p65	NULL
--	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
is	NULL
increased	NULL
by	NULL
DZA	NULL
.	NULL

A	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
nuclear	NULL
protein	NULL
was	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibodies	NULL
against	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
dose-response	NULL
effect	NULL
of	NULL
DZA	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
not	NULL
stimulated	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
pg	NULL
of	NULL
each	NULL
nuclear	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
p65	NULL
was	NULL
performed	NULL
.	NULL

C	NULL
,	NULL
time-response	NULL
effect	NULL
of	NULL
DZA	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
times	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
nuclear	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
p65	NULL
was	NULL
performed	NULL
.	NULL

Data	NULL
illustrated	NULL
are	NULL
from	NULL
a	NULL
single	NULL
experiment	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
total	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

without	NULL
DTT	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
DTT	NULL
from	NULL
the	NULL
assay	NULL
could	NULL
not	NULL
modulate	NULL
each	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
which	NULL
were	NULL
presented	NULL
by	NULL
DTT	NULL
in	NULL
an	NULL
assay	NULL
with	NULL
DTT	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
DZA	NULL
inhibition	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
is	NULL
not	NULL
caused	NULL
by	NULL
a	NULL
loss	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Nuclear	NULL
Translocation	NULL
of	NULL
NF-kB	NULL
Is	NULL
Increased	NULL
by	NULL
DZA-We	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
DZA	NULL
on	NULL
the	NULL
translocation	NULL
of	NULL
p65	NULL
(	NULL
Rel-A	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
into	NULL
the	NULL
nucleus	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
using	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

LPS	NULL
stimulation	NULL
increased	NULL
protein	NULL
levels	NULL
of	NULL
each	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Treatment	NULL
of	NULL
DZA	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
100	NULL
uM	NULL
induced	NULL
an	NULL
increase	NULL
of	NULL
Rel	NULL
family	NULL
proteins	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
regardless	NULL
of	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
exact	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
which	NULL
shows	NULL
that	NULL
DZA	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
potentiates	NULL
its	NULL
LPS-induced	NULL
translocation	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
established	NULL
the	NULL
modulation	NULL
of	NULL
p65	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
by	NULL
DZA	NULL
at	NULL
either	NULL
various	NULL
concentrations	NULL
or	NULL
various	NULL
time	NULL
intervals	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
DZA	NULL
at	NULL
100	NULL
um	NULL
concentration	NULL
increased	NULL
the	NULL
levels	NULL
of	NULL
p65	NULL
in	NULL
the	NULL
nucleus	NULL
regardless	NULL
of	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3C	NULL
shows	NULL
the	NULL
modulation	NULL
of	NULL
p65	NULL
level	NULL
in	NULL
the	NULL
nucleus	NULL
by	NULL
treatment	NULL
of	NULL
DZA	NULL
at	NULL
various	NULL
time	NULL
intervals	NULL
.	NULL

p65	NULL
in	NULL
the	NULL
nucleus	NULL
increased	NULL
remarkably	NULL
at	NULL
60	NULL
and	NULL
120	NULL
min	NULL
after	NULL
treatment	NULL
with	NULL
DZA	NULL
,	NULL
even	NULL
though	NULL
there	NULL
was	NULL
a	NULL
slight	NULL
decrease	NULL
at	NULL
15	NULL
min	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
cellular	NULL
p65	NULL
was	NULL
not	NULL
modulated	NULL
by	NULL
DZA	NULL
,	NULL
whereas	NULL
the	NULL
amount	NULL
of	NULL
cytoplasmic	NULL
p65	NULL
decreased	NULL
proportionally	NULL
to	NULL
the	NULL
increase	NULL
of	NULL
nuclear	NULL
p65	NULL
by	NULL
DZA	NULL
as	NULL
measured	NULL
in	NULL
a	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cellular	NULL
extracts	NULL
and	NULL
cytoplasmic	NULL
fractions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
DZA	NULL
increases	NULL
the	NULL
amount	NULL
of	NULL
p65	NULL
nuclear	NULL
translocation	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
the	NULL
increase	NULL
of	NULL
p65	NULL
in	NULL
the	NULL
nucleus	NULL
by	NULL
DZA	NULL
is	NULL
caused	NULL
only	NULL
by	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
18984	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
not	NULL
by	NULL
the	NULL
enhancement	NULL
of	NULL
p65	NULL
expression	NULL
.	NULL

LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
Transcriptional	NULL
Activity	NULL
Is	NULL
Inhibited	NULL
by	NULL
DZA	NULL
,	NULL
and	NULL
This	NULL
Inhibitory	NULL
Effect	NULL
Is	NULL
Augmented	NULL
by	NULL
the	NULL
Addition	NULL
of	NULL
Hcey-Since	NULL
DZA	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
without	NULL
a	NULL
diminution	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
we	NULL
proved	NULL
the	NULL
effects	NULL
of	NULL
DZA	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
by	NULL
transient	NULL
transfection	NULL
experiments	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
using	NULL
reporter	NULL
gene	NULL
constructs	NULL
carrying	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
J16	NULL
)	NULL
NF-kB	NULL
binding	NULL
sequence	NULL
or	NULL
mutant	NULL
(	NULL
J32	NULL
)	NULL
NF-kB	NULL
binding	NULL
sequence	NULL
in	NULL
front	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
specifically	NULL
respond	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
83	NULL
)	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
J16	NULL
resulted	NULL
in	NULL
a	NULL
4.7-fold	NULL
induction	NULL
of	NULL
CAT	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
induction	NULL
of	NULL
CAT	NULL
expression	NULL
by	NULL
LPS	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
J32	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
LPS	NULL
stimulation	NULL
resulted	NULL
in	NULL
a	NULL
drastic	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
CAT	NULL
expression	NULL
.	NULL

LPS-induced	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
dose	NULL
dependently	NULL
inhibited	NULL
by	NULL
DZA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
DZA	NULL
potently	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
by	NULL
LPS	NULL
,	NULL
even	NULL
though	NULL
it	NULL
more	NULL
intensely	NULL
provokes	NULL
the	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Hey	NULL
on	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
was	NULL
examined	NULL
.	NULL

There	NULL
was	NULL
a	NULL
tendency	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
more	NULL
than	NULL
the	NULL
inhibition	NULL
observed	NULL
by	NULL
DZA	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
DZA-Hey	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
CAT	NULL
expression	NULL
induced	NULL
by	NULL
expression	NULL
of	NULL
p65	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
CAT-reporter	NULL
plasmids	NULL
and	NULL
pSVL65	NULL
that	NULL
express	NULL
large	NULL
amounts	NULL
of	NULL
p65	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pSVL	NULL
substituting	NULL
for	NULL
pSVL65	NULL
.	NULL

After	NULL
6	NULL
h	NULL
of	NULL
transfection	NULL
,	NULL
one	NULL
group	NULL
of	NULL
cells	NULL
was	NULL
exposed	NULL
for	NULL
18	NULL
h	NULL
to	NULL
100	NULL
um	NULL
DZA	NULL
and	NULL
the	NULL
other	NULL
was	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
p65	NULL
induced	NULL
a	NULL
5.9-fold	NULL
increase	NULL
of	NULL
CAT	NULL
protein	NULL
,	NULL
driven	NULL
from	NULL
J16	NULL
under	NULL
the	NULL
absence	NULL
of	NULL
DZA	NULL
treatment	NULL
,	NULL
but	NULL
did	NULL
not	NULL
induce	NULL
CAT	NULL
protein	NULL
expression	NULL
from	NULL
J32	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CAT	NULL
protein	NULL
was	NULL
completely	NULL
inhibited	NULL
from	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
pSVL65	NULL
when	NULL
DZA	NULL
was	NULL
treated	NULL
into	NULL
cells	NULL
at	NULL
the	NULL
concentration	NULL
of	NULL
100	NULL
um	NULL
,	NULL
although	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
expression	NULL
in	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
pSVL	NULL
65	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
in	NULL
the	NULL
cells	NULL
only	NULL
stimulated	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
production	NULL
of	NULL
p65	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
DZA	NULL
as	NULL
monitored	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-p65	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
showing	NULL
DZA	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
,	NULL
suggest	NULL
that	NULL
DZA	NULL
directly	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
p65	NULL
but	NULL
not	NULL
at	NULL
the	NULL
signal	NULL
cascade	NULL
of	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

To	NULL
elucidate	NULL
whether	NULL
any	NULL
of	NULL
the	NULL
observed	NULL
effects	NULL
could	NULL
be	NULL
due	NULL
to	NULL
DZA-Hey	NULL
,	NULL
cells	NULL
to	NULL
be	NULL
exposed	NULL
to	NULL
100	NULL
um	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
LPS	NULL
stimulation	NULL
were	NULL
pretreated	NULL
with	NULL
a	NULL
more	NULL
specific	NULL
and	NULL
potent	NULL
inhibitor	NULL
of	NULL
S-adenosylhomocysteine	NULL
hydrolase	NULL
,	NULL
DZAri	NULL
,	NULL
to	NULL
block	NULL
the	NULL
intracellular	NULL
accumulation	NULL
of	NULL
DZA-Hey	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
DZAri	NULL
almost	NULL
completely	NULL
abrogated	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
DZA	NULL
,	NULL
indicating	NULL
a	NULL
central	NULL
role	NULL
for	NULL
DZA-Hcy	NULL
in	NULL
the	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
.	NULL

No	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
DZAri	NULL
alone	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
exogenous	NULL
DZA-Hcy	NULL
is	NULL
capable	NULL
of	NULL
inhibition	NULL
,	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
100	NULL
um	NULL
DZA-Hcy	NULL
for	NULL
1	NULL
h	NULL
before	NULL
LPS	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
exogenous	NULL
DZA-Hcy	NULL
failed	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
in	NULL
the	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
,	NULL
demonstrating	NULL
that	NULL
DZA-Hecy	NULL
is	NULL
incapable	NULL
of	NULL
inhibition	NULL
when	NULL
given	NULL
exogenously	NULL
.	NULL

LPS-induced	NULL
Phosphorylation	NULL
of	NULL
p65	NULL
Is	NULL
Inhibited	NULL
by	NULL
The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
DZA-To	NULL
determine	NULL
if	NULL
DZA	NULL
might	NULL
inhibit	NULL
the	NULL
functional	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
modifying	NULL
phosphorylation	NULL
of	NULL
p65	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
phosphorylation	NULL
of	NULL
p65	NULL
in	NULL
LPS-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
DZA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
LPS	NULL
induced	NULL
a	NULL
strong	NULL
phosphorylation	NULL
of	NULL
p65	NULL
.	NULL

In	NULL
cells	NULL
pretreated	NULL
with	NULL
100	NULL
um	NULL
DZA	NULL
,	NULL
however	NULL
,	NULL
LPS-induced	NULL
phosphorylation	NULL
of	NULL
p65	NULL
was	NULL
markedly	NULL
reduced	NULL
.	NULL

A	NULL
low	NULL
constitutive	NULL
phosphorylation	NULL
of	NULL
p65	NULL
was	NULL
observed	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
reduced	NULL
by	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
DZA	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
DZA	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
hindrance	NULL
of	NULL
p65	NULL
phosphorylation	NULL
required	NULL
for	NULL
the	NULL
functional	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
Transcriptional	NULL
Activity	NULL
Is	NULL
Inhibited	NULL
by	NULL
DZA-We	NULL
tried	NULL
to	NULL
determine	NULL
if	NULL
DZA	NULL
could	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
without	NULL
affecting	NULL
nuclear	NULL
translocation	NULL
in	NULL
non-hematopoietic	NULL
cells	NULL
stimulated	NULL
by	NULL
other	NULL
inducers	NULL
of	NULL
NF-kB	NULL
.	NULL

TNF-	NULL
«	NULL
stimulation	NULL
of	NULL
COS-7	NULL
cells	NULL
prominently	NULL
induced	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
,	NULL
which	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
100	NULL
um	NULL
DZA	NULL
to	NULL
COS-7	NULL
cells	NULL
before	NULL
TNF-	NULL
@	NULL
stimulation	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
nuclear	NULL
translocation	NULL
or	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
suggesting	NULL
that	NULL
DZA	NULL
did	NULL
not	NULL
affect	NULL
TNF-	NULL
«	NULL
-induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
COS-7	NULL
cells	NULL
.	NULL

DZA	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
transient	NULL
transfection	NULL
experiments	NULL
of	NULL
COS-7	NULL
cells	NULL
using	NULL
reporter	NULL
gene	NULL
constructs	NULL
(	NULL
J16	NULL
or	NULL
J32	NULL
)	NULL
,	NULL
TNF	NULL
-	NULL
«	NULL
stimulation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
J16	NULL
resulted	NULL
in	NULL
CAT	NULL
expression	NULL
that	NULL
was	NULL
2.6-fold	NULL
greater	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

No	NULL
induction	NULL
of	NULL
CAT	NULL
expression	NULL
by	NULL
TNF-a	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
J32	NULL
.	NULL

Treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
100	NULL
um	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
TNF-	NULL
@	NULL
stimulation	NULL
resulted	NULL
in	NULL
complete	NULL
inhibition	NULL
of	NULL
CAT	NULL
protein	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
that	NULL
DZA	NULL
is	NULL
a	NULL
common	NULL
and	NULL
potent	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
induced	NULL
by	NULL
distinct	NULL
stimuli	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Hey	NULL
on	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
was	NULL
examined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
DZA	NULL
dose	NULL
dependently	NULL
inhibited	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
in	NULL
cells	NULL
stimulated	NULL
by	NULL
TNF-a	NULL
.	NULL

Combination	NULL
of	NULL
DZA	NULL
and	NULL
Hey	NULL
more	NULL
potently	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
than	NULL
inhibition	NULL
observed	NULL
by	NULL
DZA	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
DZA-Hey	NULL
in	NULL
COS-7	NULL
cells	NULL
stimulated	NULL
with	NULL
TNFa	NULL
.	NULL

Cells	NULL
co-transfected	NULL
with	NULL
pSVL65	NULL
and	NULL
CAT-reporter	NULL
plasmid	NULL
(	NULL
J16	NULL
or	NULL
J32	NULL
)	NULL
showed	NULL
a	NULL
3.0-fold	NULL
expression	NULL
of	NULL
CAT	NULL
protein	NULL
driven	NULL
from	NULL
J16	NULL
,	NULL
but	NULL
not	NULL
from	NULL
J32	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

100	NULL
um	NULL
DZA	NULL
strongly	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
protein	NULL
in	NULL
cells	NULL
expressing	NULL
p65	NULL
,	NULL
suggesting	NULL
that	NULL
DZA	NULL
directly	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
p65	NULL
.	NULL

DZA	NULL
Induces	NULL
Proteolytic	NULL
Degradation	NULL
of	NULL
IxBa	NULL
,	NULL
but	NULL
Not	NULL
IxBB-Translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
into	NULL
the	NULL
nucleus	NULL
is	NULL
linked	NULL
to	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IB	NULL
proteins	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
as	NULL
we	NULL
have	NULL
described	NULL
above	NULL
,	NULL
DZA	NULL
increases	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
DZA	NULL
promotes	NULL
proteolytic	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
DZA	NULL
following	NULL
stimulation	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IxBa	NULL
protein	NULL
was	NULL
notably	NULL
reduced	NULL
by	NULL
treatment	NULL
of	NULL
DZA	NULL
alone	NULL
for	NULL
2	NULL
h	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
100	NULL
unm	NULL
.	NULL

The	NULL
I	NULL
«	NULL
Ba	NULL
protein	NULL
was	NULL
fully	NULL
recovered	NULL
at	NULL
1	NULL
h	NULL
after	NULL
LPS	NULL
stimulation	NULL
without	NULL
DZA	NULL
,	NULL
since	NULL
IxBa	NULL
is	NULL
autoregulated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
3	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
DZA	NULL
pretreatment	NULL
before	NULL
LPS	NULL
prevented	NULL
synthesis	NULL
of	NULL
IxBa	NULL
which	NULL
was	NULL
recovered	NULL
when	NULL
treated	NULL
with	NULL
LPS	NULL
alone	NULL
,	NULL
indicating	NULL
that	NULL
DZA	NULL
interfered	NULL
with	NULL
the	NULL
synthesis	NULL
of	NULL
IxBa	NULL
because	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
inhibited	NULL
by	NULL
DZA	NULL
.	NULL

Resynthesis	NULL
of	NULL
IxBa	NULL
after	NULL
stimulation	NULL
of	NULL
LPS	NULL
was	NULL
more	NULL
potently	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
Hey	NULL
plus	NULL
DZA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
IxBa	NULL
levels	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
at	NULL
various	NULL
time	NULL
inter	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
MJ16	NULL
(	NULL
wt	NULL
)	NULL
CJ32	NULL
(	NULL
mt	NULL
)	NULL
Fold	NULL
Induction	NULL
LPs	NULL
-	NULL
+	NULL
+	NULL
DZA	NULL
-	NULL
-	NULL
+	NULL
+	NULL
5	NULL
none	NULL
O	NULL
Hey	NULL
Fold	NULL
Induction	NULL
t	NULL
LPs	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
DZA	NULL
-	NULL
-	NULL
1	NULL
10	NULL
__	NULL
100	NULL
MJ16	NULL
(	NULL
wt	NULL
)	NULL
AJ32	NULL
(	NULL
mt	NULL
)	NULL
moo	NULL
B	NULL
a	NULL
®	NULL
~	NULL
Fold	NULL
Induction	NULL
Fold	NULL
Induction	NULL
1	NULL
0	NULL
LPS	NULL
-	NULL
+	NULL
+	NULL
DZA	NULL
-	NULL
-	NULL
+	NULL
DZAri	NULL
-	NULL
-	NULL
-	NULL
+	NULL
DZA-Hcy	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
++	NULL
+	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
is	NULL
inhibited	NULL
by	NULL
DZA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
reporter	NULL
gene	NULL
constructs	NULL
carrying	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
J16	NULL
,	NULL
M	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
or	NULL
mutant	NULL
type	NULL
(	NULL
J32	NULL
,	NULL
]	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
in	NULL
front	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
NF-xB	NULL
transcriptional	NULL
activity	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
J16	NULL
(	NULL
®	NULL
or	NULL
J82	NULL
(	NULL
C	NULL
]	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
.	NULL

After	NULL
18	NULL
h	NULL
of	NULL
stimulation	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
lyzed	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

B	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
Hey	NULL
on	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
DZA	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
J16	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
or	NULL
without	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
dosages	NULL
(	NULL
uM	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
@	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
C	NULL
)	NULL
)	NULL
of	NULL
Hey	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
.	NULL

After	NULL
18	NULL
h	NULL
of	NULL
stimulation	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

C	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
in	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
pSVL65	NULL
expressing	NULL
p65	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
pSVL65	NULL
and	NULL
J16	NULL
(	NULL
®	NULL
,	NULL
or	NULL
with	NULL
pSVL65	NULL
and	NULL
J32	NULL
(	NULL
]	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
18985	NULL
DZA	NULL
LPS	NULL
|	NULL
-	NULL
+	NULL
+	NULL
>	NULL
&	NULL
©	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

LPS-induced	NULL
phosphorylation	NULL
of	NULL
p65	NULL
is	NULL
inhibited	NULL
by	NULL
DZA	NULL
.	NULL

Phosphate-labeled	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
DZA	NULL
(	NULL
100	NULL
pM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
stimulated	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
1	NULL
h	NULL
,	NULL
p65	NULL
was	NULL
recovered	NULL
by	NULL
immunoprecipitation	NULL
using	NULL
specific	NULL
antibody	NULL
and	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
an	NULL
independent	NULL
experiment	NULL
.	NULL

p65	NULL
vals	NULL
.	NULL

IxBa	NULL
levels	NULL
were	NULL
reduced	NULL
from	NULL
their	NULL
level	NULL
at	NULL
60	NULL
min	NULL
to	NULL
their	NULL
level	NULL
at	NULL
120	NULL
min	NULL
after	NULL
treatment	NULL
with	NULL
DZA	NULL
,	NULL
and	NULL
this	NULL
reduction	NULL
was	NULL
continued	NULL
to	NULL
240	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
DZA	NULL
promotes	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
prevents	NULL
its	NULL
resynthesis	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
results	NULL
reasonably	NULL
support	NULL
that	NULL
DZA	NULL
increases	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

A	NULL
different	NULL
I	NULL
«	NULL
B	NULL
isoform	NULL
,	NULL
IBB	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
regulators	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
whose	NULL
kinetics	NULL
is	NULL
slower	NULL
than	NULL
that	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
NF-kB	NULL
inducers	NULL
such	NULL
as	NULL
LPS	NULL
(	NULL
6	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
IxBB	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
LPS	NULL
for	NULL
1	NULL
h	NULL
without	NULL
pretreatment	NULL
of	NULL
DZA	NULL
led	NULL
to	NULL
the	NULL
disappearance	NULL
of	NULL
IBB	NULL
,	NULL
which	NULL
would	NULL
normally	NULL
exist	NULL
in	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
unstimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

The	NULL
disappearance	NULL
of	NULL
I	NULL
«	NULL
BB	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
cells	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
DZA	NULL
at	NULL
increasing	NULL
concentrations	NULL
following	NULL
stimulation	NULL
with	NULL
LPS	NULL
.	NULL

Interestingly	NULL
,	NULL
treatment	NULL
of	NULL
100	NULL
uM	NULL
DZA	NULL
alone	NULL
for	NULL
2	NULL
h	NULL
at	NULL
several	NULL
concentrations	NULL
could	NULL
not	NULL
reduce	NULL
the	NULL
level	NULL
of	NULL
IxBB	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
,	NULL
and	NULL
IxBB	NULL
remained	NULL
continuously	NULL
until	NULL
4	NULL
h	NULL
after	NULL
exposure	NULL
of	NULL
100	NULL
um	NULL
DZA	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
DZA	NULL
can	NULL
not	NULL
lead	NULL
to	NULL
I	NULL
«	NULL
BB	NULL
down-regulation	NULL
,	NULL
and	NULL
the	NULL
down-reg-ulation	NULL
of	NULL
I	NULL
«	NULL
B	NULL
#	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
enhanced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
mediated	NULL
by	NULL
DZA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

DZA-induced	NULL
Proteolytic	NULL
Degradation	NULL
of	NULL
IxBa	NULL
Is	NULL
Neither	NULL
Modulated	NULL
by	NULL
Hey	NULL
nor	NULL
Involved	NULL
in	NULL
IKK	NULL
Complex	NULL
Activation-The	NULL
addition	NULL
of	NULL
100	NULL
um	NULL
Hey	NULL
potentiated	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
Hey	NULL
can	NULL
potentiate	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
DZA	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
100	NULL
uM	NULL
Hey	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
additional	NULL
treatment	NULL
of	NULL
Hey	NULL
could	NULL
not	NULL
modulate	NULL
the	NULL
proteolytic	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
IxBa	NULL
.	NULL

The	NULL
treatment	NULL
of	NULL
Hey	NULL
alone	NULL
could	NULL
not	NULL
reduce	NULL
IxBa	NULL
at	NULL
all	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
synergic	NULL
effect	NULL
of	NULL
Hcy	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
increasing	NULL
times	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
DZA-induced	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
is	NULL
dissociated	NULL
from	NULL
the	NULL
accumulation	NULL
of	NULL
DZA-Hey	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
IKK	NULL
complexes	NULL
consisting	NULL
of	NULL
IKKa	NULL
and	NULL
IKK	NULL
control	NULL
phosphorylation	NULL
of	NULL
IB	NULL
proteins	NULL
in	NULL
cytokine-induced	NULL
activation	NULL
pathway	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

We	NULL
tried	NULL
to	NULL
determine	NULL
if	NULL
IKK	NULL
complexes	NULL
can	NULL
participate	NULL
in	NULL
the	NULL
down-regu-	NULL
were	NULL
transfected	NULL
with	NULL
pSVL	NULL
substituting	NULL
pSVL65	NULL
.	NULL

At	NULL
6	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
100	NULL
uM	NULL
DZA	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
18	NULL
h.	NULL
And	NULL
then	NULL
cells	NULL
were	NULL
lysed	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

D	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
derivatives	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
J16	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
100	NULL
pM	NULL
DZA	NULL
or	NULL
100	NULL
um	NULL
DZA-Hey	NULL
before	NULL
stimulation	NULL
.	NULL

For	NULL
the	NULL
DZAri	NULL
treatment	NULL
,	NULL
100	NULL
uM	NULL
DZAri	NULL
was	NULL
given	NULL
1	NULL
h	NULL
before	NULL
DZA	NULL
treatment	NULL
.	NULL

After	NULL
18	NULL
h	NULL
of	NULL
stimulation	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/m	NULL
!	NULL

l	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

Determination	NULL
of	NULL
CAT	NULL
expression	NULL
was	NULL
performed	NULL
using	NULL
CAT	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
kit	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

(	NULL
r	NULL
=	NULL
8	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
18986	NULL
A	NULL
DZA	NULL
=	NULL
-	NULL
-	NULL
+	NULL
+	NULL
TNF	NULL
=	NULL
-	NULL
+	NULL
+	NULL
-NF-	NULL
«	NULL
B	NULL
MJ16	NULL
(	NULL
wt	NULL
)	NULL
OJ32	NULL
(	NULL
mt	NULL
)	NULL
Fold	NULL
Induction	NULL
D	NULL
DZA	NULL
=	NULL
=	NULL
+	NULL
+	NULL
C	NULL
4	NULL
none	NULL
5	NULL
3	NULL
OHey	NULL
6	NULL
3	NULL
£	NULL
;	NULL
k=	NULL
]	NULL
2	NULL
1	NULL
0	NULL
TNF	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
DZA	NULL
=-	NULL
-	NULL
1	NULL
10	NULL
100	NULL
(	NULL
wt	NULL
)	NULL
g	NULL
(	NULL
mt	NULL
)	NULL
C	NULL
0	NULL
3	NULL
C	NULL
A-	NULL
<	NULL
G	NULL
LL	NULL
.	NULL

p6S	NULL
=	NULL
+	NULL
+	NULL
#	NULL
DZA	NULL
=	NULL
=	NULL
+	NULL
+	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
is	NULL
inhibited	NULL
by	NULL
DZA	NULL
in	NULL
COS-7	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
recombinant	NULL
GST-human	NULL
TNF-	NULL
@	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
1	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
each	NULL
nuclear	NULL
protein	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
DNA	NULL
binding	NULL
reaction	NULL
with	NULL
°*P-end-labeled	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
,	NULL
and	NULL
then	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

B	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
NF-KB	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
reporter	NULL
gene	NULL
constructs	NULL
carrying	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
J16	NULL
,	NULL
IB	NULL
)	NULL
or	NULL
mutant	NULL
type	NULL
(	NULL
J82	NULL
,	NULL
C	NULL
]	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
in	NULL
front	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
.	NULL

After	NULL
18	NULL
h	NULL
of	NULL
stimulation	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
TNF-a	NULL
(	NULL
50	NULL
ng/m1	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

C	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
Hey	NULL
on	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
DZA	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
J16	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
or	NULL
without	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
dosages	NULL
(	NULL
M	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
®	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
C	NULL
]	NULL
)	NULL
of	NULL
Hey	NULL
(	NULL
100	NULL
um	NULL
)	NULL
.	NULL

After	NULL
18	NULL
h	NULL
of	NULL
stimulation	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
TNF-a	NULL
(	NULL
50	NULL
ng/m1	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

D	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
DZA	NULL
in	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
pSVL65	NULL
expressing	NULL
p65	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
pSVL65	NULL
and	NULL
J16	NULL
(	NULL
R	NULL
,	NULL
or	NULL
with	NULL
pSVL65	NULL
and	NULL
J82	NULL
(	NULL
]	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pSVL	NULL
substituting	NULL
pSVL65	NULL
.	NULL

At	NULL
6	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
100	NULL
uM	NULL
DZA	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
18	NULL
h.	NULL
And	NULL
then	NULL
cells	NULL
were	NULL
lysed	NULL
to	NULL
determine	NULL
the	NULL
The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
A	NULL
-_	NULL
DZA	NULL
_	NULL
-	NULL
-	NULL
1	NULL
10	NULL
100	NULL
1	NULL
10	NULL
100	NULL
LPS	NULL
-o	NULL
t	NULL
#	NULL
40	NULL
ko-	NULL
-o-izbe	NULL
B	NULL
Min	NULL
__	NULL
0	NULL
5	NULL
15	NULL
30	NULL
60	NULL
90	NULL
120	NULL
240	NULL
Ix	NULL
B	NULL
a	NULL
we-	NULL
sem	NULL
mao	NULL
_-_	NULL
C	NULL
DZA	NULL
-	NULL
-	NULL
1	NULL
10	NULL
100	NULL
1	NULL
10	NULL
100	NULL
LPS	NULL
-o	NULL
to	NULL
#	NULL
#	NULL
0	NULL
$	NULL
0-	NULL
-o-|	NULL
«	NULL
B	NULL
B	NULL
band	NULL
we	NULL
we	NULL
ue	NULL
D	NULL
Min	NULL
0	NULL
5	NULL
15	NULL
30	NULL
60	NULL
90	NULL
120	NULL
240	NULL
Ix	NULL
B	NULL
B	NULL
«	NULL
»	NULL
oo	NULL
co	NULL
or	NULL
oP	NULL
on	NULL
on	NULL
op	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

DZA	NULL
induces	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

A	NULL
,	NULL
dose-response	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
IxBa	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
not	NULL
stimulated	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
IxBa	NULL
was	NULL
performed	NULL
.	NULL

B	NULL
,	NULL
time-response	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
IkxBa	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
times	NULL
,	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
IxBa	NULL
was	NULL
performed	NULL
.	NULL

C	NULL
,	NULL
dose-response	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
IBB	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
DZA	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
M	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
or	NULL
not	NULL
stimulated	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
pug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
IBB	NULL
was	NULL
performed	NULL
.	NULL

D	NULL
,	NULL
time-response	NULL
effect	NULL
of	NULL
DZA	NULL
on	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
times	NULL
,	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
IBB	NULL
was	NULL
performed	NULL
.	NULL

Data	NULL
illustrated	NULL
are	NULL
from	NULL
a	NULL
single	NULL
experiment	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
total	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

lation	NULL
of	NULL
IxBa	NULL
by	NULL
DZA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8C	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
LPS	NULL
for	NULL
15	NULL
min	NULL
severely	NULL
activated	NULL
IKK	NULL
complexes	NULL
leading	NULL
to	NULL
excessive	NULL
phosphorylation	NULL
of	NULL
recombinant	NULL
IxBa	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
exposure	NULL
with	NULL
100	NULL
um	NULL
DZA	NULL
from	NULL
15	NULL
to	NULL
240	NULL
min	NULL
never	NULL
activated	NULL
IKK	NULL
complexes	NULL
,	NULL
showing	NULL
that	NULL
DZA-induced	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
is	NULL
independent	NULL
of	NULL
activation	NULL
of	NULL
IKK	NULL
complexes	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
the	NULL
dual	NULL
effects	NULL
of	NULL
DZA	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
NF-KB	NULL
,	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
promotion	NULL
of	NULL
IxBa	NULL
degradation	NULL
.	NULL

A	NULL
hypothetical	NULL
diagram	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
DZA	NULL
is	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

There	NULL
have	NULL
been	NULL
many	NULL
reports	NULL
that	NULL
described	NULL
some	NULL
interesting	NULL
properties	NULL
of	NULL
DZA	NULL
,	NULL
including	NULL
the	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
cytokines	NULL
and	NULL
cell	NULL
adhesion	NULL
molecules	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
and	NULL
an	NULL
anti-HIV	NULL
effect	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
numerous	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
which	NULL
promote	NULL
several	NULL
diseases	NULL
is	NULL
well	NULL
known	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
study	NULL
(	NULL
26	NULL
)	NULL
and	NULL
this	NULL
paper	NULL
shows	NULL
that	NULL
DZA	NULL
potently	NULL
inhibited	NULL
the	NULL
transcription	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
TNF-a	NULL
«	NULL
and	NULL
IL-1	NULL
.	NULL

Additionally	NULL
,	NULL
other	NULL
researchers	NULL
reported	NULL
that	NULL
the	NULL
adherence	NULL
of	NULL
cells	NULL
was	NULL
inhibited	NULL
through	NULL
the	NULL
suppression	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
of	NULL
CAT	NULL
.	NULL

Determination	NULL
of	NULL
CAT	NULL
expression	NULL
was	NULL
performed	NULL
using	NULL
CAT	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
kit	NULL
.	NULL

Values	NULL
are	NULL
mean	NULL
*	NULL
S.D	NULL
.	NULL

(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
A	NULL
-	NULL
DZA	NULL
1	NULL
10	NULL
100	NULL
1	NULL
10	NULL
100	NULL
Hey	NULL
_o	NULL
e	NULL
-	NULL
-	NULL
t	NULL
t	NULL
+	NULL
o+	NULL
#	NULL
lea	NULL
<	NULL
n	NULL
come	NULL
come	NULL
cas	NULL
came	NULL
--	NULL
cae	NULL
B	NULL
DZA	NULL
-	NULL
15	NULL
30	NULL
60	NULL
120	NULL
15	NULL
30	NULL
60	NULL
120	NULL
Hey	NULL
<	NULL
0	NULL
-	NULL
-	NULL
-	NULL
-	NULL
404	NULL
+o	NULL
1x	NULL
B	NULL
a	NULL
wee	NULL
toes	NULL
eme	NULL
*-*	NULL
e	NULL
's	NULL
se	NULL
«	NULL
C_	NULL
DZA	NULL
-	NULL
6	NULL
D	NULL
@	NULL
W2MAM-	NULL
-	NULL
Min	NULL
LPS	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
15	NULL
Min	NULL
1x	NULL
B	NULL
a	NULL
C	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

DZA-induced	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
is	NULL
neither	NULL
modulated	NULL
by	NULL
Hey	NULL
nor	NULL
involved	NULL
in	NULL
IKK	NULL
complex	NULL
activation	NULL
.	NULL

A	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
DZA	NULL
for	NULL
2	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
100	NULL
uM	NULL
Hey	NULL
,	NULL
and	NULL
then	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
specific	NULL
antibody	NULL
against	NULL
IxBa	NULL
.	NULL

B	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
Hey	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
times	NULL
,	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
specific	NULL
antibody	NULL
against	NULL
IxBa	NULL
was	NULL
performed	NULL
.	NULL

C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
DZA	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
times	NULL
,	NULL
total	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
IKK	NULL
complexes	NULL
were	NULL
recovered	NULL
by	NULL
immunoprecipitation	NULL
.	NULL

IKK	NULL
assay	NULL
was	NULL
accomplished	NULL
using	NULL
recombinant	NULL
protein	NULL
of	NULL
GST-IxBa	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
an	NULL
independent	NULL
experiment	NULL
.	NULL

3-deazaadenosine	NULL
\	NULL
homocysteine	NULL
1	NULL
3-deazaadenosyIhomocysteine	NULL
a	NULL
/	NULL
7	NULL
/	NULL
Ix	NULL
Ba	NULL
degradation	NULL
NF-	NULL
x	NULL
B	NULL
translocation	NULL
&	NULL
DNA—bind	NULL
‘	NULL
mg/	NULL
2	NULL
NF-	NULL
x	NULL
B-mediated	NULL
(	NULL
T	NULL
&	NULL
transcription	NULL
Inhibition	NULL
of	NULL
Cytokine	NULL
Expression	NULL
Induction	NULL
of	NULL
Apoptosis	NULL
Anti-HIV	NULL
Effect	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Hypothetical	NULL
diagram	NULL
illustrating	NULL
the	NULL
effects	NULL
of	NULL
DZA	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
regulation	NULL
.	NULL

expression	NULL
by	NULL
DZA	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
they	NULL
provided	NULL
for	NULL
the	NULL
possibility	NULL
of	NULL
DZA	NULL
as	NULL
a	NULL
potent	NULL
therapeutic	NULL
agent	NULL
for	NULL
diseases	NULL
in	NULL
which	NULL
these	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
play	NULL
a	NULL
central	NULL
pathogenic	NULL
role	NULL
,	NULL
the	NULL
mechanism	NULL
has	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

Since	NULL
these	NULL
cytokines	NULL
and	NULL
adherence	NULL
molecules	NULL
are	NULL
included	NULL
in	NULL
specific	NULL
target	NULL
genes	NULL
of	NULL
NF-KB	NULL
,	NULL
this	NULL
study	NULL
successfully	NULL
explains	NULL
how	NULL
DZA	NULL
inhibits	NULL
the	NULL
expression	NULL
of	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
.	NULL

Beg	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
reported	NULL
that	NULL
a	NULL
phenotype	NULL
of	NULL
the	NULL
p65	NULL
'~	NULL
mice	NULL
died	NULL
during	NULL
embryonic	NULL
development	NULL
through	NULL
massive	NULL
apoptosis	NULL
of	NULL
hepatocytes	NULL
,	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
might	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
protecting	NULL
cells	NULL
from	NULL
apoptosis	NULL
,	NULL
instead	NULL
of	NULL
promoting	NULL
growth	NULL
of	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
recent	NULL
reports	NULL
(	NULL
38-41	NULL
)	NULL
have	NULL
described	NULL
a	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
blocking	NULL
apoptosis	NULL
induced	NULL
by	NULL
TNF	NULL
.	NULL

18987	NULL
Interestingly	NULL
,	NULL
this	NULL
protective	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
apparent	NULL
not	NULL
only	NULL
against	NULL
TNF	NULL
but	NULL
also	NULL
against	NULL
cells	NULL
treated	NULL
with	NULL
ionizing	NULL
radiation	NULL
or	NULL
chemotherapeutic	NULL
agents	NULL
(	NULL
89	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
role	NULL
of	NULL
the	NULL
Rel	NULL
proteins	NULL
in	NULL
oncogenic	NULL
transformation	NULL
is	NULL
quite	NULL
well	NULL
established	NULL
,	NULL
and	NULL
it	NULL
is	NULL
now	NULL
clear	NULL
that	NULL
Rel	NULL
proteins	NULL
malignantly	NULL
transform	NULL
and	NULL
immortalize	NULL
cells	NULL
by	NULL
inducing	NULL
expression	NULL
of	NULL
specific	NULL
genes	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
the	NULL
possibility	NULL
that	NULL
some	NULL
of	NULL
the	NULL
target	NULL
genes	NULL
for	NULL
Rel-mediated	NULL
oncogenesis	NULL
and	NULL
for	NULL
NF-	NULL
«	NULL
B-mediated	NULL
blockage	NULL
of	NULL
apoptosis	NULL
may	NULL
be	NULL
identi-cal	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
strongly	NULL
suggested	NULL
that	NULL
agents	NULL
which	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
may	NULL
have	NULL
both	NULL
direct	NULL
anti-can-cer	NULL
effects	NULL
and	NULL
effects	NULL
that	NULL
facilitate	NULL
apoptosis	NULL
in	NULL
tumor	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
DZA	NULL
induced	NULL
apoptosis	NULL
in	NULL
lympho-cytic	NULL
mouse	NULL
leukemia	NULL
L1210	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
report	NULL
showed	NULL
that	NULL
even	NULL
though	NULL
DZA	NULL
raised	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
during	NULL
apoptosis	NULL
induction	NULL
,	NULL
e-mye	NULL
transcription	NULL
that	NULL
is	NULL
a	NULL
downstream	NULL
target	NULL
gene	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
1	NULL
,	NULL
42	NULL
)	NULL
was	NULL
markedly	NULL
reduced	NULL
at	NULL
the	NULL
early	NULL
stage	NULL
of	NULL
apoptosis	NULL
induction	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
reduction	NULL
of	NULL
e-mye	NULL
transcription	NULL
in	NULL
DZA-induced	NULL
apoptosis	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
HL-60	NULL
cells	NULL
by	NULL
other	NULL
researchers	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
that	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
may	NULL
entirely	NULL
serve	NULL
as	NULL
a	NULL
potent	NULL
inducing	NULL
factor	NULL
or	NULL
may	NULL
participate	NULL
at	NULL
least	NULL
in	NULL
part	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
DZA	NULL
in	NULL
tumor	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
these	NULL
findings	NULL
point	NULL
to	NULL
DZA	NULL
as	NULL
a	NULL
useful	NULL
chemotherapeutic	NULL
agent	NULL
which	NULL
may	NULL
prevent	NULL
malignant	NULL
transformation	NULL
of	NULL
normal	NULL
cells	NULL
into	NULL
tumor	NULL
cells	NULL
and	NULL
induce	NULL
apoptosis	NULL
of	NULL
tumor	NULL
cells	NULL
through	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
whose	NULL
enhancer	NULL
elements	NULL
are	NULL
located	NULL
in	NULL
HIV-long	NULL
terminal	NULL
repeats	NULL
,	NULL
is	NULL
a	NULL
key	NULL
molecule	NULL
of	NULL
HIV	NULL
replication	NULL
for	NULL
the	NULL
pathogenesis	NULL
of	NULL
AIDS	NULL
(	NULL
45	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NF-kB	NULL
may	NULL
be	NULL
a	NULL
target	NULL
for	NULL
the	NULL
therapy	NULL
of	NULL
AIDS	NULL
.	NULL

Previously	NULL
,	NULL
other	NULL
researchers	NULL
described	NULL
that	NULL
DZA	NULL
may	NULL
have	NULL
an	NULL
anti-HIV	NULL
effect	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
but	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
effect	NULL
has	NULL
not	NULL
been	NULL
understood	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
DZA	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
described	NULL
in	NULL
this	NULL
study	NULL
explains	NULL
how	NULL
DZA	NULL
can	NULL
exert	NULL
an	NULL
anti-HIV	NULL
effect	NULL
as	NULL
described	NULL
by	NULL
other	NULL
researchers	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
by	NULL
DZA	NULL
suggests	NULL
that	NULL
DZA	NULL
may	NULL
inhibit	NULL
the	NULL
replication	NULL
of	NULL
HIV	NULL
,	NULL
implying	NULL
that	NULL
DZA	NULL
may	NULL
be	NULL
a	NULL
useful	NULL
drug	NULL
for	NULL
the	NULL
therapeutic	NULL
treatment	NULL
of	NULL
AIDS	NULL
.	NULL

Naumann	NULL
and	NULL
Scheidereit	NULL
(	NULL
46	NULL
)	NULL
described	NULL
that	NULL
p65	NULL
is	NULL
strongly	NULL
phosphorylated	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vivo	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
demonstrated	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
regulated	NULL
through	NULL
phosphorylation	NULL
of	NULL
p65	NULL
by	NULL
cAMP-independent	NULL
activation	NULL
of	NULL
a	NULL
catalytic	NULL
subunit	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKAc	NULL
)	NULL
associated	NULL
with	NULL
IB	NULL
proteins	NULL
by	NULL
a	NULL
mechanism	NULL
which	NULL
signals	NULL
caused	NULL
degradation	NULL
of	NULL
IxB	NULL
proteins	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
PKAc	NULL
and	NULL
subsequent	NULL
phosphorylation	NULL
of	NULL
p65	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
DZA	NULL
disturbed	NULL
the	NULL
phosphorylation	NULL
of	NULL
p65	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

So	NULL
,	NULL
we	NULL
suggest	NULL
a	NULL
possibility	NULL
that	NULL
accumulated	NULL
cellular	NULL
DZA-Hey	NULL
,	NULL
caused	NULL
by	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
DZA	NULL
,	NULL
might	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
PKAc	NULL
associated	NULL
with	NULL
IB	NULL
proteins	NULL
,	NULL
or	NULL
interrupt	NULL
the	NULL
PKAc-mediated	NULL
phosphorylation	NULL
of	NULL
p65	NULL
directly	NULL
or	NULL
indirectly	NULL
.	NULL

SB203580	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
and	NULL
elevated	NULL
intracellular	NULL
cAMP	NULL
has	NULL
been	NULL
represented	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
already	NULL
bound	NULL
to	NULL
DNA	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
,	NULL
DZA	NULL
and	NULL
these	NULL
inhibitors	NULL
share	NULL
a	NULL
similarity	NULL
that	NULL
all	NULL
of	NULL
them	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
without	NULL
affecting	NULL
its	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
there	NULL
is	NULL
a	NULL
definite	NULL
difference	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
SB203580	NULL
and	NULL
elevated	NULL
cellular	NULL
cAMP	NULL
,	NULL
DZA	NULL
inhibits	NULL
the	NULL
phosphorylation	NULL
of	NULL
p65	NULL
.	NULL

This	NULL
study	NULL
indicates	NULL
that	NULL
DZA	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
through	NULL
a	NULL
hindrance	NULL
of	NULL
p65	NULL
phosphorylation	NULL
by	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
18988	NULL
the	NULL
accumulation	NULL
of	NULL
DZA-Hcy	NULL
in	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
we	NULL
can	NULL
not	NULL
totally	NULL
rule	NULL
out	NULL
that	NULL
DZA	NULL
independent	NULL
of	NULL
cellular	NULL
DZA-Hey	NULL
accumulation	NULL
,	NULL
may	NULL
have	NULL
interfered	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
report	NULL
by	NULL
Backlund	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
,	NULL
treatment	NULL
with	NULL
100	NULL
um	NULL
DZA	NULL
resulted	NULL
in	NULL
significant	NULL
accumulation	NULL
of	NULL
DZA-Hey	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
Hey	NULL
to	NULL
DZA	NULL
increased	NULL
the	NULL
accumulation	NULL
of	NULL
DZA-Hey	NULL
to	NULL
about	NULL
5	NULL
times	NULL
the	NULL
level	NULL
caused	NULL
by	NULL
DZA	NULL
alone	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
a	NULL
greatly	NULL
increased	NULL
accumulation	NULL
of	NULL
DZA-Hcy	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
Hey	NULL
to	NULL
DZA	NULL
treatment	NULL
in	NULL
the	NULL
cells	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
slightly	NULL
potentiated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
Hey	NULL
to	NULL
DZA	NULL
.	NULL

We	NULL
described	NULL
that	NULL
DZA	NULL
promotes	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
«	NULL
Ba	NULL
,	NULL
but	NULL
not	NULL
IxBfB	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
an	NULL
increase	NULL
of	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Increased	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
nucleus	NULL
by	NULL
DZA	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
DZA-induced	NULL
apoptosis	NULL
in	NULL
L1210	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
DZA	NULL
might	NULL
reduce	NULL
I	NULL
«	NULL
Ba	NULL
in	NULL
this	NULL
case	NULL
.	NULL

However	NULL
,	NULL
a	NULL
DZA-mediated	NULL
increase	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
was	NULL
not	NULL
discernable	NULL
in	NULL
COS-7	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
DZA-mediated	NULL
IxBa	NULL
degradation	NULL
is	NULL
cell-type	NULL
specific	NULL
.	NULL

A	NULL
number	NULL
of	NULL
kinases	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
phosphorylate	NULL
IxBa	NULL
,	NULL
and	NULL
recently	NULL
a	NULL
high	NULL
molecular	NULL
mass	NULL
,	NULL
approximately	NULL
700	NULL
kDa	NULL
,	NULL
kinase	NULL
complex	NULL
termed	NULL
IKK	NULL
(	NULL
7-9	NULL
)	NULL
was	NULL
identified	NULL
.	NULL

However	NULL
,	NULL
DZA	NULL
mediates	NULL
IxBa	NULL
degradation	NULL
through	NULL
an	NULL
IKK-independent	NULL
pathway	NULL
and	NULL
DZA	NULL
can	NULL
stimulate	NULL
other	NULL
kinase	NULL
pathways	NULL
.	NULL

We	NULL
conclude	NULL
this	NULL
because	NULL
IKK	NULL
was	NULL
not	NULL
activated	NULL
at	NULL
all	NULL
by	NULL
DZA	NULL
while	NULL
it	NULL
was	NULL
intensely	NULL
activated	NULL
by	NULL
LPS	NULL
in	NULL
this	NULL
study	NULL
.	NULL

One	NULL
notable	NULL
fact	NULL
is	NULL
that	NULL
DZA	NULL
stimulates	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
but	NULL
not	NULL
IBB	NULL
.	NULL

Among	NULL
kinases	NULL
which	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
including	NULL
IKK	NULL
,	NULL
none	NULL
can	NULL
selectively	NULL
differentiate	NULL
between	NULL
IxBa	NULL
and	NULL
I	NULL
«	NULL
xBB	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
expect	NULL
that	NULL
DZA	NULL
might	NULL
be	NULL
a	NULL
valuable	NULL
probe	NULL
to	NULL
identify	NULL
kinases	NULL
that	NULL
function	NULL
with	NULL
only	NULL
I	NULL
«	NULL
Ba	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
DZA	NULL
has	NULL
dual	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
regulation	NULL
.	NULL

One	NULL
is	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
already	NULL
bound	NULL
to	NULL
target	NULL
DNA	NULL
,	NULL
and	NULL
another	NULL
is	NULL
the	NULL
promotion	NULL
of	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Although	NULL
the	NULL
wide	NULL
variety	NULL
of	NULL
biological	NULL
properties	NULL
observed	NULL
with	NULL
DZA	NULL
has	NULL
emphasized	NULL
that	NULL
DZA	NULL
is	NULL
to	NULL
be	NULL
an	NULL
effective	NULL
drug	NULL
for	NULL
treatment	NULL
of	NULL
human	NULL
diseases	NULL
including	NULL
inflammation	NULL
,	NULL
infections	NULL
,	NULL
and	NULL
tu-mors	NULL
,	NULL
the	NULL
mechanism	NULL
and	NULL
target	NULL
molecules	NULL
of	NULL
DZA	NULL
's	NULL
action	NULL
have	NULL
never	NULL
been	NULL
elucidated	NULL
.	NULL

This	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
specific	NULL
target	NULL
molecule	NULL
of	NULL
DZA	NULL
and	NULL
suggests	NULL
that	NULL
DZA	NULL
may	NULL
be	NULL
a	NULL
potent	NULL
drug	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
diseases	NULL
in	NULL
which	NULL
NF-kB	NULL
plays	NULL
an	NULL
important	NULL
pathogenic	NULL
role	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
useful	NULL
tool	NULL
for	NULL
studying	NULL
the	NULL
regulation	NULL
and	NULL
physiological	NULL
functions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Acknowledgment-We	NULL
appreciate	NULL
Dr.	NULL
David	NULL
Baltimore	NULL
,	NULL
California	NULL
Institute	NULL
of	NULL
Technology	NULL
,	NULL
Pasadena	NULL
,	NULL
CA	NULL
,	NULL
for	NULL
the	NULL
kind	NULL
donations	NULL
of	NULL
J16	NULL
and	NULL
J82	NULL
.	NULL

REFERENCES	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
141-179	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Koedood	NULL
,	NULL
M.	NULL
,	NULL
Piffat	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
Oncogene	NULL
13	NULL
,	NULL
1367-1378	NULL
3	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
May	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Kopp	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16	NULL
,	NULL
225-260	NULL
4	NULL
.	NULL

Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Stevenson	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Schwarz	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Antwerp	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Miyamoto	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
2723-2735	NULL
5	NULL
.	NULL

Whiteside	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Epinat	NULL
,	NULL
J.-C.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
lled	NULL
~	NULL
o	NULL
10	NULL
:	NULL
Kopp	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Ghosh	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
956-959	NULL
12	NULL
.	NULL

18	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20.	NULL
.	NULL

Flexner	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Hildreth	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Kuncl	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Drachman	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38.	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Mayo	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
784-787	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45.	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
4597-4607	NULL
47	NULL
.	NULL

48	NULL
.	NULL

The	NULL
Effects	NULL
of	NULL
3-Deazaadenosine	NULL
on	NULL
NF-kB	NULL
Regulation	NULL
1413-1426	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
649-681	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
Zhu	NULL
,	NULL
H.	NULL
,	NULL
Murray	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Schevchenko	NULL
,	NULL
A.	NULL
,	NULL
Bennett	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
J.	NULL
,	NULL
Young	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Barbosa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mann	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
860-866	NULL
.	NULL

Woronicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Gao	NULL
,	NULL
X.	NULL
,	NULL
Cao	NULL
,	NULL
Z.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
866-869	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
Rothwarf	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Delbase	NULL
,	NULL
M.	NULL
,	NULL
Hayakawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
91	NULL
,	NULL
248-252	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Mannel	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Droge	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1181-1194	NULL
Griscavage	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wilk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Ignarro	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
3308-3312	NULL
Scheinman	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Cogswell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Lofquist	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
270	NULL
,	NULL
283-286	NULL
Auphan	NULL
N.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
,	NULL
Helmberg	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Krin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
270	NULL
,	NULL
286-290	NULL
Wesselborg	NULL
,	NULL
S.	NULL
,	NULL
Bauer	NULL
,	NULL
M.	NULL
K.	NULL
A.	NULL
,	NULL
Vogt	NULL
,	NULL
M.	NULL
,	NULL
Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
12422-12429	NULL
Ollivier	NULL
,	NULL
V.	NULL
,	NULL
Parry	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
,	NULL
Cobb	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
de	NULL
Prost	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
20828-20885	NULL
Chiang	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Richards	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
and	NULL
Cantoni	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1977	NULL
)	NULL
Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

18	NULL
,	NULL
939-947	NULL
Aksamit	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Falk	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Cantoni	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257	NULL
,	NULL
621-625	NULL
Chiang	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Cantoni	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1979	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

28	NULL
,	NULL
1897-1902	NULL
Lancet	NULL
889	NULL
,	NULL
488	NULL
Mayers	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Mikovits	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Joshi	NULL
,	NULL
B.	NULL
,	NULL
Hewlett	NULL
,	NULL
I.	NULL
K.	NULL
,	NULL
Estrada	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Wolfe	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Garcia	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Doctor	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Burke	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Gordon	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Lane	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Chiang	NULL
,	NULL
P.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
215-219	NULL
Medzibradsky	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Zimmerman	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Wolberg	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Elion	NULL
,	NULL
G.	NULL
B	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
J.	NULL
Immunopharmacol	NULL
.	NULL

4	NULL
,	NULL
29-41	NULL
Krenitsky	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Rideout	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Chao	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
Koszalka	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Gurney	NULL
,	NULL
F.	NULL
,	NULL
Crouch	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Cohn	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Wolberg	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Vinegar	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Med	NULL
.	NULL

Chem	NULL
.	NULL

29	NULL
,	NULL
138-148	NULL
Zimmerman	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Wolberg	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Duncan	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1978	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

75	NULL
,	NULL
6220-6224	NULL
Jeong	NULL
,	NULL
S.-Y	NULL
.	NULL

,	NULL
Lee	NULL
,	NULL
J.-H.	NULL
,	NULL
Kim	NULL
,	NULL
H.-S.	NULL
,	NULL
Hong	NULL
,	NULL
S.-H.	NULL
,	NULL
Cheong	NULL
,	NULL
C.-H.	NULL
,	NULL
and	NULL
Kim	NULL
,	NULL
L	NULL
-K.	NULL
(	NULL
1996	NULL
)	NULL
Immunology	NULL
89	NULL
,	NULL
558-562	NULL
Jurgensen	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Huber	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Zimmerman	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
and	NULL
Wolberg	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
653-661	NULL
Shankar	NULL
,	NULL
R.	NULL
,	NULL
de	NULL
la	NULL
Motte	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
DiCorleto	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
9376-9382	NULL
Endresen	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Eide	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Aarbakke	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

46	NULL
,	NULL
1898-1901	NULL
Kim	NULL
,	NULL
L-K.	NULL
,	NULL
Li	NULL
,	NULL
C.-C.	NULL
H.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Lee	NULL
,	NULL
J.-H.	NULL
,	NULL
Kim	NULL
,	NULL
H.-S.	NULL
,	NULL
Pardhasaradhi	NULL
,	NULL
K.	NULL
,	NULL
Garcia	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Chiang	NULL
,	NULL
P.	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biomed	NULL
.	NULL

Sci	NULL
.	NULL

4	NULL
,	NULL
83-90	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Fan	NULL
,	NULL
C.-H.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
287-294	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hayakawa	NULL
,	NULL
M.	NULL
,	NULL
Rothwarf	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Zandi	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
888	NULL
,	NULL
548-554	NULL
Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
28-32	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Bronson	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
876	NULL
,	NULL
167-170	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
782-784	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
V.	NULL
,	NULL
Martin	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kafri	NULL
,	NULL
T.	NULL
,	NULL
Green	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
187-789	NULL
Liu	NULL
,	NULL
Z.-G.	NULL
,	NULL
Hsu	NULL
,	NULL
H.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
565-576	NULL
Duyao	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Buckler	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
4727-4731	NULL
Duerre	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Buttz	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
and	NULL
Ackerman	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

70	NULL
,	NULL
703-711	NULL
.	NULL

Loennechen	NULL
,	NULL
T.	NULL
,	NULL
Moens	NULL
,	NULL
U.	NULL
,	NULL
Kildalsen	NULL
,	NULL
H.	NULL
,	NULL
Andersen	NULL
,	NULL
A.	NULL
,	NULL
Rekvig	NULL
,	NULL
O.	NULL
P.	NULL
,	NULL
and	NULL
Aarbakke	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Pharmacol	NULL
.	NULL

Toxicol	NULL
.	NULL

81	NULL
,	NULL
199-204	NULL
Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
826	NULL
,	NULL
711-713	NULL
Zhong	NULL
,	NULL
H.	NULL
,	NULL
Su¥Yang	NULL
,	NULL
H.	NULL
,	NULL
Erdjument-Brommage	NULL
,	NULL
H.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ghosh	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
89	NULL
,	NULL
413-424	NULL
Backlund	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
Carotti	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Cantoni	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1986	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

160	NULL
,	NULL
245-251	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
3-Deazaadenosine	NULL
,	NULL
a	NULL
S-Adenosylhomocysteine	NULL
Hydrolase	NULL
Inhibitor	NULL
,	NULL
Has	NULL
Dual	NULL
Effects	NULL
on	NULL
NF-	NULL
KB	NULL
Regulation	NULL
:	NULL
INHIBITION	NULL
OF	NULL
NF-	NULL
«	NULL
xB	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
AND	NULL
PROMOTION	NULL
OF	NULL
I	NULL
xBo	NULL
DEGRADATION	NULL
Seong-	NULL
Yun	NULL
Jeong	NULL
,	NULL
Sang-Gun	NULL
Ahn	NULL
,	NULL
Jeong-Hwa	NULL
Lee	NULL
,	NULL
Ho-Shik	NULL
Kim	NULL
,	NULL
Jin-Woo	NULL
Kim	NULL
,	NULL
Hyangshuk	NULL
Rhim	NULL
,	NULL
Seong-Whan	NULL
Jeong	NULL
and	NULL
In-Kyung	NULL
Kim	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:18981-18988.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.27.18981	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/27/18981	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
48	NULL
references	NULL
,	NULL
23	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

